Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Bush Health Advisor Phelps Gives BIO Good Administration Contact

  • News

Executive Summary

The selection of Anne Phelps as White House special assistant for domestic policy on healthcare gives the Biotechnology Industry Organization a key contact in the Bush Administration for genetic research and privacy issues.

You may also be interested in...



HIAA VP Rosen Returns To Hill As Staff Director For Frist Subcommittee

Former Health Insurance Association of America VP-Policy Dean Rosen will be Sen. Frist's (R-Tenn.) health staff contact as staff director for the Senate Health/Public Health Subcommittee.

HIAA VP Rosen Returns To Hill As Staff Director For Frist Subcommittee

Former Health Insurance Association of America VP-Policy Dean Rosen will be Sen. Frist's (R-Tenn.) health staff contact as staff director for the Senate Health/Public Health Subcommittee.

Merck Chairman Gilmartin Named To Bush's HHS Transition Advisory Team

Merck Chairman Ray Gilmartin is one of 19 outside health advisors on President-elect George W. Bush's HHS transition team.

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says

New EU Filings

See All
UsernamePublicRestriction

Register

PS037240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By